CRU Hungary Kft.

The medical center is at the forefront of research in cardiovascular diseases and metabolic disorders, focusing on innovative treatments for conditions such as hypertriglyceridemia and atherosclerosis.

• Hypertriglyceridemia
• Atherosclerotic Cardiovascular Disease
• Severe Hypertriglyceridemia

Through the study of novel agents like olezarsen, the center is advancing the understanding of lipid metabolism and its impact on cardiovascular health.

Specializing in chronic obstructive pulmonary disease (COPD), the center is dedicated to improving patient outcomes through cutting-edge research on therapies like benralizumab, which targets eosinophilic inflammation in the respiratory tract.

• Chronic Obstructive Pulmonary Disease (COPD)
• Frequent COPD Exacerbations
• Elevated Peripheral Blood Eosinophils

The center's work is pivotal in reducing exacerbation rates and enhancing the quality of life for individuals with severe respiratory conditions.

In the field of rheumatology, the center is renowned for its research on rheumatoid arthritis, particularly in evaluating the efficacy of treatments like upadacitinib and adalimumab for patients with inadequate responses to conventional therapies.

• Rheumatoid Arthritis
• Upadacitinib and Adalimumab Efficacy
• Methotrexate-Resistant Cases

By exploring new therapeutic avenues, the center is contributing to the development of more effective management strategies for chronic inflammatory diseases.